HLA‐DR3介导的CD4 T细胞对1型糖尿病患者GAD65的应答

Abstract Aim We planned this study to identify diabetogenic glutamic acid decarboxylase (GAD65) peptides possibly responsible for human leucocyte antigen (HLA)‐DR3/DQ2‐mediated activation of GAD65‐specific CD4 T cells in type 1 diabetes (T1D). Methods Top 30 GAD65 peptides, found to strongly bind in...

Full description

Bibliographic Details
Main Authors: Neihenuo Chuzho, Neetu Mishra, Nikhil Tandon, Uma Kanga, Gunja Mishra, Akanksha Sharma, Narinder K. Mehra, Neeraj Kumar
Format: Article
Language:English
Published: Wiley 2023-07-01
Series:Journal of Diabetes
Subjects:
Online Access:https://doi.org/10.1111/1753-0407.13406
_version_ 1797780517992529920
author Neihenuo Chuzho
Neetu Mishra
Nikhil Tandon
Uma Kanga
Gunja Mishra
Akanksha Sharma
Narinder K. Mehra
Neeraj Kumar
author_facet Neihenuo Chuzho
Neetu Mishra
Nikhil Tandon
Uma Kanga
Gunja Mishra
Akanksha Sharma
Narinder K. Mehra
Neeraj Kumar
author_sort Neihenuo Chuzho
collection DOAJ
description Abstract Aim We planned this study to identify diabetogenic glutamic acid decarboxylase (GAD65) peptides possibly responsible for human leucocyte antigen (HLA)‐DR3/DQ2‐mediated activation of GAD65‐specific CD4 T cells in type 1 diabetes (T1D). Methods Top 30 GAD65 peptides, found to strongly bind in silico with HLA‐DR3/DQ2 molecules, were selected and grouped into four pools. The peptides were used to stimulate CD4 T cells of study subjects in 16‐h peripheral blood mononuclear cell culture. CD4 T cells' stimulation in terms of interferon‐gamma (IFN‐γ), interleukin (IL)‐17, tumor necrosis factor‐alpha (TNF‐α), and IL‐10 expression was analyzed using flow cytometry. Results Although all four GAD65 peptide pools (PP1‐4) resulted in significantly higher expression of IFN‐γ by CD4 T cells (p = .003, p < .0001, p = .026, and p = .002, respectively), only pool 2 showed significant increase in IL‐17 expression (p < .0001) in T1D patients vs healthy controls. Interpeptide group comparison for immunogenicity revealed significantly higher IFN‐γ and IL‐17 expressions and significantly lower IL‐10 expression for PP2 compared to other groups (p < .0001, p = .02, and p = .04, respectively) in patients but not in controls. Further, group 2 peptides resulted in significant increase in CD4 T cells' expression of IFN‐γ and IL‐17 (p = .002 for both) and significant decrease in IL‐10 (p = .04) in HLA‐DRB1*03‐DQA1*05‐DQB1*02+ patients vs HLA‐DRB1*03‐DQA1*05‐DQB1*02+ controls. The CD4 T cells' expression of IL‐17 was significantly higher (p = .03) in recently diagnosed vs long‐standing HLA‐DRB1*03‐DQA1*05‐DQB1*02+ T1D patients. Conclusion GAD65 peptides, particularly those belonging to PP2, induced CD4 T cells to express IFN‐γ and IL‐17 cytokines in T1D patients, suggesting that group 2 peptides possibly presented by HLA‐DR3 molecule to CD4 T cells shift immune balance toward inflammatory phenotype in patients.
first_indexed 2024-03-12T23:45:13Z
format Article
id doaj.art-29ef37f916e442c4abfe137d2e417e0c
institution Directory Open Access Journal
issn 1753-0393
1753-0407
language English
last_indexed 2024-03-12T23:45:13Z
publishDate 2023-07-01
publisher Wiley
record_format Article
series Journal of Diabetes
spelling doaj.art-29ef37f916e442c4abfe137d2e417e0c2023-07-14T08:11:48ZengWileyJournal of Diabetes1753-03931753-04072023-07-0115760762110.1111/1753-0407.13406HLA‐DR3介导的CD4 T细胞对1型糖尿病患者GAD65的应答Neihenuo Chuzho0Neetu Mishra1Nikhil Tandon2Uma Kanga3Gunja Mishra4Akanksha Sharma5Narinder K. Mehra6Neeraj Kumar7Indian Council of Medical Research (ICMR)‐National Institute of Pathology Safdarjung Hospital Campus New Delhi IndiaSymbiosis School of Biological Sciences Symbiosis International (Deemed University) Pune IndiaDepartment of Endocrinology and Metabolism All India Institute of Medical Sciences New Delhi IndiaDepartment of Transplant Immunology and Immunogenetics All India Institute of Medical Sciences New Delhi IndiaIndian Council of Medical Research (ICMR)‐National Institute of Pathology Safdarjung Hospital Campus New Delhi IndiaDepartment of Transplant Immunology and Immunogenetics All India Institute of Medical Sciences New Delhi IndiaEmeritus Scientist (ICMR), and Former Dean (Research) All India Institute of Medical Sciences New Delhi IndiaIndian Council of Medical Research (ICMR)‐National Institute of Pathology Safdarjung Hospital Campus New Delhi IndiaAbstract Aim We planned this study to identify diabetogenic glutamic acid decarboxylase (GAD65) peptides possibly responsible for human leucocyte antigen (HLA)‐DR3/DQ2‐mediated activation of GAD65‐specific CD4 T cells in type 1 diabetes (T1D). Methods Top 30 GAD65 peptides, found to strongly bind in silico with HLA‐DR3/DQ2 molecules, were selected and grouped into four pools. The peptides were used to stimulate CD4 T cells of study subjects in 16‐h peripheral blood mononuclear cell culture. CD4 T cells' stimulation in terms of interferon‐gamma (IFN‐γ), interleukin (IL)‐17, tumor necrosis factor‐alpha (TNF‐α), and IL‐10 expression was analyzed using flow cytometry. Results Although all four GAD65 peptide pools (PP1‐4) resulted in significantly higher expression of IFN‐γ by CD4 T cells (p = .003, p < .0001, p = .026, and p = .002, respectively), only pool 2 showed significant increase in IL‐17 expression (p < .0001) in T1D patients vs healthy controls. Interpeptide group comparison for immunogenicity revealed significantly higher IFN‐γ and IL‐17 expressions and significantly lower IL‐10 expression for PP2 compared to other groups (p < .0001, p = .02, and p = .04, respectively) in patients but not in controls. Further, group 2 peptides resulted in significant increase in CD4 T cells' expression of IFN‐γ and IL‐17 (p = .002 for both) and significant decrease in IL‐10 (p = .04) in HLA‐DRB1*03‐DQA1*05‐DQB1*02+ patients vs HLA‐DRB1*03‐DQA1*05‐DQB1*02+ controls. The CD4 T cells' expression of IL‐17 was significantly higher (p = .03) in recently diagnosed vs long‐standing HLA‐DRB1*03‐DQA1*05‐DQB1*02+ T1D patients. Conclusion GAD65 peptides, particularly those belonging to PP2, induced CD4 T cells to express IFN‐γ and IL‐17 cytokines in T1D patients, suggesting that group 2 peptides possibly presented by HLA‐DR3 molecule to CD4 T cells shift immune balance toward inflammatory phenotype in patients.https://doi.org/10.1111/1753-0407.13406CD4 T细胞细胞因子GAD65HLA1型糖尿病
spellingShingle Neihenuo Chuzho
Neetu Mishra
Nikhil Tandon
Uma Kanga
Gunja Mishra
Akanksha Sharma
Narinder K. Mehra
Neeraj Kumar
HLA‐DR3介导的CD4 T细胞对1型糖尿病患者GAD65的应答
Journal of Diabetes
CD4 T细胞
细胞因子
GAD65
HLA
1型糖尿病
title HLA‐DR3介导的CD4 T细胞对1型糖尿病患者GAD65的应答
title_full HLA‐DR3介导的CD4 T细胞对1型糖尿病患者GAD65的应答
title_fullStr HLA‐DR3介导的CD4 T细胞对1型糖尿病患者GAD65的应答
title_full_unstemmed HLA‐DR3介导的CD4 T细胞对1型糖尿病患者GAD65的应答
title_short HLA‐DR3介导的CD4 T细胞对1型糖尿病患者GAD65的应答
title_sort hla dr3介导的cd4 t细胞对1型糖尿病患者gad65的应答
topic CD4 T细胞
细胞因子
GAD65
HLA
1型糖尿病
url https://doi.org/10.1111/1753-0407.13406
work_keys_str_mv AT neihenuochuzho hladr3jièdǎodecd4txìbāoduì1xíngtángniàobìnghuànzhěgad65deyīngdá
AT neetumishra hladr3jièdǎodecd4txìbāoduì1xíngtángniàobìnghuànzhěgad65deyīngdá
AT nikhiltandon hladr3jièdǎodecd4txìbāoduì1xíngtángniàobìnghuànzhěgad65deyīngdá
AT umakanga hladr3jièdǎodecd4txìbāoduì1xíngtángniàobìnghuànzhěgad65deyīngdá
AT gunjamishra hladr3jièdǎodecd4txìbāoduì1xíngtángniàobìnghuànzhěgad65deyīngdá
AT akankshasharma hladr3jièdǎodecd4txìbāoduì1xíngtángniàobìnghuànzhěgad65deyīngdá
AT narinderkmehra hladr3jièdǎodecd4txìbāoduì1xíngtángniàobìnghuànzhěgad65deyīngdá
AT neerajkumar hladr3jièdǎodecd4txìbāoduì1xíngtángniàobìnghuànzhěgad65deyīngdá